Literature DB >> 1505297

Antibiotic-associated colitis and cystic fibrosis.

C S Pokorny1, P T Bye, C MacLeod, W S Selby.   

Abstract

The use of antibiotics in patients with cystic fibrosis is widespread, and fecal carriage of Clostridium difficile occurs in up to 50% of these patients; however, antibiotic-associated colitis appears to be a rare occurrence. The reasons why this is so remain unknown. A case of antibiotic-associated colitis occurring in a patient with cystic fibrosis is described. Possible mechanisms for the rarity of antibiotic-associated colitis are reviewed and implications for prompt diagnosis and therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1505297     DOI: 10.1007/bf01296021

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis.

Authors:  S L Peach; S P Borriello; H Gaya; F E Barclay; A R Welch
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

2.  Clostridium difficile toxin A induces a specific antisecretory factor which protects against intestinal mucosal damage.

Authors:  J Torres; E Jennische; S Lange; I Lönnroth
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

3.  Antibiotic associated pseudomembranous colitis with negative proctosigmoidoscopy examination.

Authors:  F J Tedesco
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

4.  Treatment of Clostridium difficile colitis.

Authors:  J G Bartlett
Journal:  Gastroenterology       Date:  1985-11       Impact factor: 22.682

5.  Pseudomembranous colitis after treatment with metronidazole.

Authors:  G Thomson; A H Clark; K Hare; W G Spilg
Journal:  Br Med J (Clin Res Ed)       Date:  1981-03-14

6.  Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis.

Authors:  T C Wu; V P McCarthy; V J Gill
Journal:  J Infect Dis       Date:  1983-07       Impact factor: 5.226

7.  Identification of Clostridium difficile as a cause of pseudomembranous colitis.

Authors:  R H George; J M Symonds; F Dimock; J D Brown; Y Arabi; N Shinagawa; M R Keighley; J Alexander-Williams; D W Burdon
Journal:  Br Med J       Date:  1978-03-18

8.  Protection against cholera in breast-fed children by antibodies in breast milk.

Authors:  R I Glass; A M Svennerholm; B J Stoll; M R Khan; K M Hossain; M I Huq; J Holmgren
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

9.  Clostridium difficile in patients with cystic fibrosis.

Authors:  C J Welkon; S S Long; C M Thompson; P H Gilligan
Journal:  Am J Dis Child       Date:  1985-08

10.  Colitis associated with metronidazole therapy.

Authors:  R Saginur; C R Hawley; J G Bartlett
Journal:  J Infect Dis       Date:  1980-06       Impact factor: 5.226

View more
  8 in total

1.  Clostridium difficile colitis in children with cystic fibrosis.

Authors:  Sunny Zaheed Hussain; Cathy Chu; David P Greenberg; David Orenstein; Seema Khan
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

2.  Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation.

Authors:  B Yates; D M Murphy; A J Fisher; F K Gould; J L Lordan; J H Dark; P A Corris
Journal:  BMJ Case Rep       Date:  2009-05-08

Review 3.  Lung transplantation for cystic fibrosis: results, indications, complications, and controversies.

Authors:  Joseph P Lynch; David M Sayah; John A Belperio; S Sam Weigt
Journal:  Semin Respir Crit Care Med       Date:  2015-03-31       Impact factor: 3.119

4.  Pseudomembranous colitis in four patients with cystic fibrosis following lung transplantation.

Authors:  B Yates; D M Murphy; A J Fisher; F K Gould; J L Lordan; J H Dark; P A Corris
Journal:  Thorax       Date:  2006-04-06       Impact factor: 9.139

5.  Clostridium difficile Infection and Proton Pump Inhibitor Use in Hospitalized Pediatric Cystic Fibrosis Patients.

Authors:  John F Pohl; Raza Patel; Jeffery T Zobell; Ellen Lin; E Kent Korgenski; Kody Crowell; Mark W Mackay; Aleesha Richman; Christian Larsen; Barbara A Chatfield
Journal:  Gastroenterol Res Pract       Date:  2011-11-15       Impact factor: 2.260

6.  Helicobacter pylori and Clostridium difficile in cystic fibrosis patients.

Authors:  Jacob Yahav; Zmira Samra; Hannah Blau; Gabriel Dinari; Gabriel Chodick; Haim Shmuely
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

7.  High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection.

Authors:  Tanya M Monaghan; Ola H Negm; Brendon MacKenzie; Mohamed R Hamed; Clifford C Shone; David P Humphreys; K Ravi Acharya; Mark H Wilcox
Journal:  Clin Exp Gastroenterol       Date:  2017-07-19

8.  Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut.

Authors:  Yanan Wang; Lex E X Leong; Rebecca L Keating; Tokuwa Kanno; Guy C J Abell; Fredrick M Mobegi; Jocelyn M Choo; Steve L Wesselingh; A James Mason; Lucy D Burr; Geraint B Rogers
Journal:  Gut Microbes       Date:  2018-10-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.